Stephens initiated coverage on shares of Illumina (NASDAQ:ILMN – Free Report) in a research note issued to investors on Thursday morning, MarketBeat Ratings reports. The brokerage issued an overweight rating and a $170.00 target price on the life sciences company’s stock. Other analysts have also recently issued reports about the stock. Bank of America cut […]